Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice

被引:166
作者
Jenkins, DE [1 ]
Hornig, YS [1 ]
Oei, Y [1 ]
Dusich, J [1 ]
Purchio, T [1 ]
机构
[1] Xenogen Corp, Alameda, CA 94501 USA
关键词
D O I
10.1186/bcr1026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Our goal was to generate xenograft mouse models of human breast cancer based on luciferase-expressing MDA-MB-231 tumor cells that would provide rapid mammary tumor growth; produce metastasis to clinically relevant tissues such as lymph nodes, lung, and bone; and permit sensitive in vivo detection of both primary and secondary tumor sites by bioluminescent imaging. Method Two clonal cell sublines of human MDA-MB-231 cells that stably expressed firefly luciferase were isolated following transfection of the parental cells with luciferase cDNA. Each subline was passaged once or twice in vivo to enhance primary tumor growth and to increase metastasis. The resulting luciferase-expressing D3H1 and D3H2LN cells were analyzed for long-term bioluminescent stability, primary tumor growth, and distal metastasis to lymph nodes, lungs, bone and soft tissues by bioluminescent imaging. Cells were injected into the mammary fat pad of nude and nude-beige mice or were delivered systemically via intracardiac injection. Metastasis was also evaluated by ex vivo imaging and histologic analysis postmortem. Results The D3H1 and D3H2LN cell lines exhibited long-term stable luciferase expression for up to 4-6 months of accumulative tumor growth time in vivo. Bioluminescent imaging quantified primary mammary fat pad tumor development and detected early spontaneous lymph node metastasis in vivo. Increased frequency of spontaneous lymph node metastasis was observed with D3H2LN tumors as compared with D3H1 tumors. With postmortem ex vivo imaging, we detected additional lung micrometastasis in mice with D3H2LN mammary tumors. Subsequent histologic evaluation of tissue sections from lymph nodes and lung lobes confirmed spontaneous tumor metastasis at these sites. Following intracardiac injection of the MDA-MB-231-luc tumor cells, early metastasis to skeletal tissues, lymph nodes, brain and various visceral organs was detected. Weekly in vivo imaging data permitted longitudinal analysis of metastasis at multiple sites simultaneously. Ex vivo imaging data from sampled tissues verified both skeletal and multiple soft tissue tumor metastasis. Conclusion This study characterized two new bioluminescent MDA-MB-231-luc human breast carcinoma cell lines with enhanced tumor growth and widespread metastasis in mice. Their application to current xenograft models of breast cancer offers rapid and highly sensitive detection options for preclinical assessment of anticancer therapies in vivo.
引用
收藏
页码:R444 / R454
页数:11
相关论文
共 20 条
[1]  
ARGUELLO F, 1988, CANCER RES, V48, P6876
[2]   BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS [J].
CAILLEAU, R ;
YOUNG, R ;
OLIVE, M ;
REEVES, WJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :661-674
[3]   Use of reporter genes for optical measurements of neoplastic disease in vivo [J].
Contag, CH ;
Jenkins, D ;
Contag, FR ;
Negrin, RS .
NEOPLASIA, 2000, 2 (1-2) :41-52
[4]  
Institute for Laboratory Animal Research (ILAR), 1996, GUID CAR US LAB
[5]   Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis [J].
Jenkins, DE ;
Oei, Y ;
Hornig, YS ;
Yu, SF ;
Dusich, J ;
Purchio, T ;
Contag, PR .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (08) :733-744
[6]   In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer [J].
Jenkins, DE ;
Yu, SF ;
Hornig, YS ;
Purchio, T ;
Contag, PR .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (08) :745-756
[7]   A multigenic program mediating breast cancer metastasis to bone [J].
Kang, YB ;
Siegel, PM ;
Shu, WP ;
Drobnjak, M ;
Kakonen, SM ;
Cordón-Cardo, C ;
Guise, TA ;
Massagué, J .
CANCER CELL, 2003, 3 (06) :537-549
[8]  
Mendel DB, 2003, CLIN CANCER RES, V9, P327
[9]   The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs [J].
Michigami, T ;
Hiraga, T ;
Williams, PJ ;
Niewolna, M ;
Nishimura, R ;
Mundy, GR ;
Yoneda, T .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 75 (03) :249-258
[10]   Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors [J].
Minn, AJ ;
Kang, YB ;
Serganova, I ;
Gupta, GP ;
Giri, DD ;
Doubrovin, M ;
Ponomarev, V ;
Gerald, WL ;
Blasberg, R ;
Massagué, J .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :44-55